HomeKURN • SWX
add
Kuros Biosciences AG
Previous close
CHFÂ 28.40
Year range
CHFÂ 6.20 - CHFÂ 32.00
Market cap
1.09B CHF
Avg Volume
223.26K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.02M | 26.84% |
Total assets | 84.54M | 18.29% |
Total liabilities | 25.79M | 74.82% |
Total equity | 58.75M | — |
Shares outstanding | 37.87M | — |
Price to book | 18.32 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2016
Website
Employees
122
